Franklin Morgan, MD
Obstetrics & Gynecology · Norfolk, VANPI 1114926425
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (57.0%), travel and lodging and education — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Lupin Inc. at 46.6% of the total. Reporting peaked in 2019 at $2,792 and has fallen 83.9% since, to $449 in 2025. Among obstetrics & gynecology clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 150 payments — averaging $34.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lupin Inc.$2K
- Astellas Pharma US Inc$379
- Currax Pharmaceuticals LLC$344
- AbbVie$233
- Novo Nordisk$228
- Pfizer$168
- plus $1K from 24 others
Across 634 payments — averaging $5625.84 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$715K
- AbbVie$578K
- Abbott$464K
- Sumitomo Pharma America, Inc.$335K
- Astellas Pharma Global Development$273K
- Sebela Pharmaceuticals Inc.$217K
- plus $985K from 17 others
What the payments were for
- Travel & lodging$1,87937%
- Food & beverage$2,91457%
- Education$3166%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lupin Inc. | 11 | $2,383 |
| Astellas Pharma US Inc | 12 | $379 |
| Currax Pharmaceuticals LLC | 23 | $344 |
| AbbVie(2 entities) | 13 | $233 |
| Novo Nordisk | 13 | $228 |
| Pfizer | 10 | $168 |
| Aspira Women's Health Inc | 4 | $153 |
| Exeltis, USA Inc. | 8 | $150 |
| Organon | 7 | $132 |
| Myovant Sciences Inc. | 7 | $118 |
| Therapeuticsmd, Inc. | 2 | $111 |
| KARL Storz Endoscopy-america | 1 | $97 |
| Bayer | 4 | $89 |
| Hologic Sales And Service, LLC | 8 | $85 |
| Mayne Pharma Commercial LLC | 4 | $73 |
| Merck | 4 | $57 |
| Sumitomo Pharma America, Inc. | 2 | $42 |
| AMAG Pharmaceuticals, Inc. | 3 | $41 |
| Amgen | 2 | $29 |
| Medtronic | 1 | $27 |
| Johnson & Johnson | 1 | $26 |
| Ferring Pharmaceuticals Inc. | 2 | $25 |
| Biogen | 1 | $23 |
| Coopersurgical, Inc. | 1 | $17 |
| Millicent US Inc | 1 | $16 |
| Covidien LP | 1 | $14 |
| Avion Pharmaceuticals | 1 | $13 |
| Mycovia Pharmaceuticals, Inc. | 1 | $13 |
| Vertical Pharmaceuticals, LLC | 1 | $12 |
| Pacira Pharmaceuticals Incorporated | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,109 in reported general payments places this provider in the 90th percentile of 992 obstetrics & gynecology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Raloxifene Hcl | 31 | $1,544 |
| Estradiol | 51 | $1,451 |
| ValacyclovirValacyclovir Hcl | 30 | $583 |
| Medroxyprogesterone Acetate | 16 | $298 |
| Alendronate Sodium | 11 | $212 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 12 | $195 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 13 | $183 |
| Escitalopram Oxalate | 11 | $169 |
| Alprazolam | 16 | $50 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Norfolk
- Thomas KimbleNorfolk$286K
- Krystle LappinenNorfolk$20K
- Joseph HudgensNorfolk$18K
- Peter TakacsNorfolk$8K
- Jack AyoubLeesburg$279K
- Kurian ThottStafford$216K
- Nina SmithHarrisonburg$199K
- Joseph TroiseSalem$144K
- Bunan AlnaifChesapeake$139K
- James JonesRichmond$134K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.